Brief Research Program Description

The Military Cardiovascular Outcomes Research program (MiCOR) is located at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. MiCOR is a multidisciplinary program that performs randomized clinical trials of novel prevention and treatment approaches to decrease the risk of cardiovascular disease in active-duty military personnel, retirees, and their dependents due to conditions including, but not limited to, combat injury, sleep disorders, eating disorders, and COVID-19. The mission of the MiCOR Program is to enhance the cardiovascular health and well-being of the Warfighter and the DoD community through innovative clinical research using precision techniques. MiCOR has a variety of clinical research studies focused on both the biomedical and behavioral components that contribute to cardiovascular risk and disease.

List of the team’s Publications/ Accomplishments Overview

The most notable accomplishments of 2022-2023 are outlined below (to date/2022-2023):

  • Peer-Reviewed Publications: 116/74
  • Book Chapters: 13/4; Books: 1/0
  • Invited Presentations: 36/19
  • Congressional Briefings: 3/1
  • Guidelines: 2/1
  • Between Jun2022 and Oct2022, as directed by 2022 NDAA Section 733, we screened 3,531 Academy first year Cadets. This resulted in 43 abnormal ECGs: 34 False Positive (rate 0.94%) in which the ECG was POSITIVE but follow on testing showed no disorder was present. 7 DISQUALIFIED, but effectively treated with 100% RTD. Additional 1200 cadets screened in July 2023. Briefed OASD (HA) 22FEB2023; Cardiovascular Clinical Community (CVCC) briefed 21FEB2023; Brief submitted to House Armed Services Committee (HASC) April 2023; Pending brief to Accessions Medical Standards Working Group (AMSWG) 05OCT2023.
  • 10 studies in active enrollment phase and protocol execution phase focused on cardiac arrest, obesity prevention, and cardiac impact of COVID-19
  • 5 studies completed protocol execution and are in analysis focused on obesity prevention, pharmacogenomics, COVID arrhythmia
  • 7 studies in or through institutional review and preparing for enrollment phase.
  • 5 studies in protocol development phase.